E.U. Eyes Six-Month Marketing Exclusivity For Pediatric Testing

Law360, New York (September 29, 2004, 12:00 AM EDT) -- The European Commission has proposed legislation to encourage pharmaceutical companies to develop more pediatric drugs in return for extended patent rights.

Advanced by the European Union’s Consumer Affairs Commissioner Olli Rehn, the bill closely mirrors the six-month extension of exclusive marketing rights granted to U.S. pharmaceutical companies for pediatric research.

The proposal, put forth on Wednesday, will require new drugs to be tested specifically on children before they are cleared for pediatric use, and aims to stimulate new research into existing medicines.

Under the proposal, most...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.